- In November 2024, BASF has partnered with Acies Bio, to advance a fermentation technology platform for producing fatty alcohols from methanol. This collaboration will strengthen BASF's sustainability efforts by enhancing its production capabilities for eco-friendly fatty alcohols
- In September 2024, Gilead Sciences and Genesis Therapeutics have entered into a strategic collaboration to discover and develop small molecule therapies across multiple targets. Genesis will utilize its advanced AI platform, GEMS, to generate and optimize molecules for targets chosen by Gilead. This partnership will enhance Gilead's drug discovery process by leveraging cutting-edge AI to accelerate the development of novel therapeutics
- In July 2022, BeiGene has formed a global strategic partnership with InnoRNA, a biotechnology company specializing in LNP-based delivery and mRNA drug discovery, to utilize its innovative platform for developing mRNA-based therapeutics. This collaboration will enhance BeiGene’s capabilities in mRNA therapeutic development, accelerating their pipeline and expanding their research potential
